Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models

British Journal of Cancer, Published online: 10 April 2024; doi:10.1038/s41416-024-02665-zNeratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models

https://www.nature.com/articles/s41416-024-02665-z

Source: British Journal of Cancer - April 10, 2024 Category: Cancer & Oncology Authors: Maryam Arshad Abul Azad Phoebe Yuen Ka Chan Vasanthy Vigneswara Katharina Feldinger Siti Norasikin Mohd Nafi Eloise Laporte-Maguire Carmela De Santo Jianmin Zuo Abeer M. Shaaban Anthony Kong Source Type: research